Health-Related Quality Of Life Of Japanese Patients With Primary Immunodeficiency Diseases Receiving IgPro20, a 20% Liquid Subcutaneous Immunoglobulin (Hizentra®)Hirokazu Kanegane, Toshio Miyawaki, Masafumi Yamada et al.|Journal of Allergy and Clinical Immunology|2014Cited by 0